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A B S T R A C T
The domestic dog is the only domestic animal species that does not produce steroids in the placenta and instead
relies on luteal steroids throughout pregnancy. Nevertheless, the canine placenta is highly responsive to steroids,
and withdrawal of progesterone (P4) affects the feto-maternal unit, initializing the parturition cascade. Similar
effects can be observed during antigestagen-induced abortion. Here, aiming to provide new insights into me-
chanisms involved in the termination of canine pregnancy, next generation sequencing (NGS, RNA-seq) was
applied. Placental transcriptomes derived from natural prepartum and antigestagen-induced abortions were
analyzed and compared with fully developed mid-gestation placentas. The contrast “prepartum luteolysis over
mid-gestation” revealed 1973 differentially expressed genes (DEG). Terms associated with apoptosis, impair-
ment of vascular function and activation of signaling of several cytokines (e.g., IL-8, IL-3, TGF-β) were over-
represented at natural luteolysis. When compared with mid-term, antigestagen treatment revealed 135 highly
regulated DEG that were involved in the induced luteolysis and showed similar associations with functional
terms and expression patterns as during natural luteolysis. The contrast “antigestagen-induced luteolysis over
prepartum luteolysis” revealed that, although similar changes occur in both conditions, they are more pro-
nounced during natural prepartum. Among P4-regulated DEG were those related to immune system and cortisol
metabolism. It appears that, besides inducing placental PGF2α output, both natural and induced P4 withdrawal
is associated with disruption of the feto-maternal interface, leading to impaired vascular functions, apoptosis and
controlled modulation of the immune response. The time-related maturation of the feto-maternal interface needs
to be considered because it may be clinically relevant.
1. Introduction
Being controlled by species-specific endocrine mechanisms, under
physiological conditions pregnancy ends with appropriately timed
parturition regulated by complex and synchronized feto-maternal
communication, in which the placenta carries a major role (Chaim and
Mazor, 1998; Nathanielsz, 1998; Olson, 2003; Lockwood, 2004;
Iliodromiti et al., 2012; Kota et al., 2013). Yet, although intensively
investigated, the molecular and endocrine mechanisms controlling
parturition are still incompletely understood in many species.
Among domestic animal species, sheep belong to those animal
models in which the underlying mechanisms have been investigated in
the greatest detail, providing knowledge for translational research
(Liggins et al., 1973; Magyar et al., 1980; Matthews and Challis, 1996).
Consequently, the current concept of the onset of parturition in mam-
mals is greatly influenced by mechanisms described for the ovine spe-
cies. These show that the signal initializing labor originates from the
fetal hypothalamic-pituitary-adrenal (HPA) axis. The maturation of the
HPA axis at the end of gestation leads to increased cortisol production
by fetal adrenal glands, resulting in activation of placental 17α-hy-
droxylase (P450C17), and thereby in an enzymatic switch of placental
steroidogenesis from the delta 4 to the delta 5 pathway (Anderson et al.,
1975). This in turn results in increased placental estrogen synthesis
(Steele et al., 1976, Challis et al., 2000). The alteration in the proges-
terone (P4):estradiol (E2) ratio in favor of the latter sensitizes the
uterus to oxytocin (OXT) by increasing expression of its receptor
https://doi.org/10.1016/j.ygcen.2019.05.019
Received 9 April 2019; Received in revised form 23 May 2019; Accepted 26 May 2019
⁎ Corresponding author at: Institute of Veterinary Anatomy, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland.
E-mail address: kowalewski@vetanat.uzh.ch (M.P. Kowalewski).
General and Comparative Endocrinology 282 (2019) 113194
Available online 27 May 2019
0016-6480/ © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
(OXTR) (Wu et al., 1996). This promotes local synthesis of uterotonic
prostaglandin F2α (PGF2α) (Meier et al., 1995).
Similarly, in cattle and pigs, a rise in estrogens is observed prior to
parturition (Robertson and King, 1974; Shenavai et al., 2012) and is
associated with increased placental activity of steroid sulfatase (STS)
which is responsible for production of active estrogens from their bio-
logically inactive sulfoconjugated forms (Schuler et al., 1994; Janszen
et al., 1995; Greven et al., 2007). Interestingly, however, in contrast to
sheep, in pigs and cattle, both of which depend on luteal P4 for
maintenance of pregnancy, active luteolysis is required for initiation of
labor, with utero-placental PGF2α acting as the main luteolytic agent
(De Rensis et al., 2012; Shenavai et al., 2012).
Departing from the regulatory mechanisms found in domestic an-
imal species in which a systemic withdrawal of P4 is observed pre-
partum, in humans and guinea pigs elevated P4 levels are still main-
tained at the time of parturition (Heap and Deanesly, 1966; Brown
et al., 2004; Nnamani et al., 2013). In these species, local, i.e., utero-
placental, functional withdrawal of P4 is implicated (Csapo and Pinto-
Dantas, 1965; Brown et al., 2004; Zakar and Hertelendy, 2007;
Nnamani et al., 2013), and cortisol together with its receptor were in-
dicated as possible antigestagenic factors (Karalis et al., 1996).
The diversity of mechanisms regulating parturition in domestic
animal species becomes even wider when the canine species is con-
sidered, in which species-specific endocrine mechanisms strongly limit
translational research. Thus, the dog is the only domestic animal species
devoid of placental steroid production (Hoffmann et al., 1994;
Nishiyama et al., 1999). However, although the canine placenta does
not produce steroids, it remains highly sensitive to luteal P4, which
plays major roles during the maintenance and termination of gestation
(Vermeirsch et al., 2000; Kowalewski et al., 2010). Interestingly, the
systemic P4 concentrations and secretion profiles are nearly identical in
pregnant and non-pregnant bitches for around 60 days of the luteal
phase/pregnancy, because there is no luteolysis in the absence of
pregnancy in the dog (reviewed in: (Kowalewski, 2014; Kowalewski,
2018) Shortly before parturition, a rapid drop in P4 occurs in pregnant
individuals signaling the onset of parturition (Nohr et al., 1993;
Hoffmann et al., 1994; Concannon, 2011). This prepartum drop in P4 is
concomitant with elevated PGF2α levels in the maternal circulation,
indicating the role of PGF2α during luteolysis and/or parturition (Nohr
et al., 1993; Hoffmann et al., 1994; Concannon, 2011). In contrast to
other domestic animal species, there is no pregnancy- and/or parturi-
tion-associated increase in estrogens in the dog (Hoffmann et al., 1994).
In fact, E2 levels decrease together with P4, further indicating the luteal
origin of E2. The elevated levels of cortisol in maternal serum prior to
delivery are inconsistent, and were related to maternal stress rather
than to the active induction of parturition (Hoffmann et al., 1994).
Regardless, increased circulating cortisol levels in maternal peripheral
plasma do not appear to be compulsory for initiation of the parturition
cascade in the dog (Hoffmann et al., 1994). The placental feto-maternal
communication between maternal stroma-derived decidual cells and
fetal trophoblast seems to be involved in underlying regulatory me-
chanisms initiating parturition in the dog (Kowalewski et al., 2010).
Thus, in the canine placenta, only decidual cells carry the nuclear P4
receptor, PGR (Vermeirsch et al., 2000; Kowalewski et al., 2010). The
prepartum increase in PGF2α appears to originate predominantly in the
fetal part of the placenta, i.e., in the trophoblast, in which the pros-
taglandin synthesizing machinery is strongly expressed during pre-
partum luteolysis (Kowalewski et al., 2010; Gram et al., 2013, 2014).
Blocking the functionality of PGR by treatment with an antigestagen,
such as aglepristone, leads to similar effects as observed during natural
withdrawal of P4, i.e., induction of placental PGF2α synthesis and in-
itiation of the prepartum signaling cascade (Nohr et al., 1993;
Kowalewski et al., 2010).
Here, given the great importance of the placental feto-maternal
communication in the initiation of canine labor, we aimed to provide
new insights into the molecular regulation of the canine placenta
during termination of pregnancy. To assess differences in global gene
expression in the canine placenta, a transcriptomic approach applying
next generation sequencing (NGS, RNA-Seq) was employed. Placental
samples collected at natural prepartum luteolysis were compared with
those samples obtained from dogs at the mid-pregnancy stage.
Furthermore, in order to better understand the involvement of P4 and
PGR-dependent downstream regulatory mechanisms during initiation
of parturition in the dog, samples were included derived from dogs in
which luteolysis/abortion was induced with the antigestagen aglepris-
tone at mid-pregnancy. To identify differences in molecular events
occurring in the placenta prior to natural parturition and/or abortion,
placental transcriptomes of both groups were compared. With this ap-
proach, the aim was to acquire new information that could be trans-
lated into clinical and breeding practices for more accurate patient
management.
To our knowledge, this is the first study providing a global tran-
scriptome analysis of the canine placenta to highlight differences be-
tween parturition and abortion, and also adding new insights into
molecular regulation of the luteolytic cascade in the dog.
2. Materials and methods
2.1. Animals and tissue sampling
Placentae from thirteen (n=13) clinically healthy, cross-breed
bitches (aged 2–8 years) were included in this study. Animals were
assigned to the following experimental groups: 1) mid-gestation (Group
1: days 35–40 of pregnancy; n= 5); 2) natural prepartum luteolysis
(Group 2: n=3); 3) antigestagen-induced luteolysis (Group 3: n=5).
The discovery samples for the RNA-Seq experiment consisted of 9 pla-
centas (n=3/per group), while TaqMan RT-qPCR validation experi-
ments were performed using all available samples (n=13 samples,
grouped as stated above). All dogs used for the study were subjected to
routine ovariohysterectomy (OVH). Dogs were mated 2 days after
ovulation, which was determined by vaginal cytology and measure-
ments of serum P4 concentrations (> 5 ng/ml) by radioimmunoassay as
described previously (Hoffmann et al., 1973; Kowalewski et al., 2009).
The day of mating represented Day 0 of gestation. The time of natural
prepartum luteolysis (Group 2) was ascertained by measurements of
serum P4 at 6 h intervals beginning on day 58 of pregnancy. Under
physiological conditions, parturition in dogs occurs 12–42 h following
the luteolytic P4 drop (Concannon et al., 1977, 1989). Therefore, in
Group 2, when P4 levels dropped below 3 ng/ml in three consecutive
measurements indicating prepartum luteolysis, OVH was performed
and tissue samples were collected. All P4 concentrations were reported
previously (Kowalewski et al., 2009). The number of animals included
in the prepartum luteolysis group was limited due to formal restrictions
by the ethics committee, resulting from the late timing of sample col-
lection (prior to the first clinical signs of parturition) and possible
danger to fetuses. Additionally, abortion was induced in bitches at mid-
pregnancy, day 40–45 (Group 3) using a P4-receptor (PGR) blocker,
aglepristone (Alizine®, Virbac, Bad Oldesloe, Germany) administrated
subcutaneously at a dose of 10mg/kg bw, twice at 24 h interval. OVH
and tissue collections were done 24 h after the second treatment.
Following surgery, placentae were separated from uteri, rinsed with
phosphate-buffered saline (PBS) and immersed in RNAlater® for 24 h at
+4 °C. After 24 h, tissue material was stored at −80 °C until RNA iso-
lation.
All animal experiments and use of tissue samples were in ac-
cordance with animal welfare legislation and were approved by the
respective authorities of the Justus Liebig University, Giessen, Germany
(permit no. II 25.3-19c20-15c GI 18/14 and VIG3-19c-20/15c GI 18,14)
and the Ondokuz Mayıs University Samsun, Turkey (Animal
Experiments Local Ethics Committee, HADYEK, permit no. 2015/82).
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2.2. RNA isolation and purification
Total RNA was isolated from separated placental samples using
TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) according to the sup-
plier’s protocol. The RNA purity and quantity were assessed with a
NanoDrop 2000C® spectrophotometer (Thermo Fischer Scientific AG,
Reinach, Switzerland). Additionally, RNA samples subjected to deep
sequencing were purified using a RNeasy® Mini Kit (Qiagen GmbH,
Hilden, Germany) following the manufacturer’s protocol. Finally, RNA
integrity was assessed with the Agilent 2200 TapeStation System. RNA
integrity numbers (RIN) ranged between 7.4 and 9.8.
2.3. RNA sequencing
RNA-Seq experiments were performed in accordance with our pre-
viously published protocol (Zatta et al., 2017). Briefly, the quality and
quantity of purified total RNA were determined with a Qubit® (1.0)
fluorometer (Life Technologies, City, California, USA) and a Bioana-
lyzer 2100 (Agilent, Waldbronn, Germany). Each RNA sample
(100–1000 ng) was used in a TruSeq RNA Sample Prep Kit v2 (Illumina,
Inc., City, California, USA) protocol for library preparation.
With this, samples were poly-A enriched and underwent reverse-
transcription to cDNA. Processing of cDNA samples included the following
steps: fragmentation, polyadenylation and ligation of TruSeq adapters.
Fragments containing adapters on both ends were selectively amplified
with PCR. Finally, the quality and quantity of enriched libraries were
evaluated using the Qubit® (1.0) fluorometer and the Caliper GX LabChip®
GX (Caliper Life Sciences, Inc., Hopkinton, MA, USA). Following normal-
ization to 10 nM, libraries were pooled. From these, 10 pM was used for
clustering in a TruSeq SR Cluster Kit v4-cBot-HS (Illumina, Inc.).
Sequencing was performed on the Illumina HiSeq4000 single end 125 bp
using the TruSeq SBS Kit v4-HS (Illumina, Inc.). The data generated herein
have been deposited in NCBI’s Gene Expression Omnibus and are acces-
sible through GEO Series accession number GSE126031.
2.4. Data evaluation
The raw data, i.e., fastq files delivered by the Illumina HiSeq4000
sequencing system were analyzed using SUSHI (Hatakeyama et al., 2016;
Qi et al., 2017), a framework for analysis of NGS data, developed at the
Functional Genomics Center Zurich (FGCZ). Briefly, after quality control,
the reads were aligned to a reference genome (the Ensembl genome build
CanFam3.1; www.ensembl.org/Canis_familiaris/Info/Index) and nor-
malized. The gene was considered detected if it had an average count of
at least 10 reads in at least one group of replicates. The generalized linear
model approach of the Bioconductor package DESeq2 (Love et al., 2014)
served to assess differential expression between experimental groups and
was used as previously reported (Zatta et al., 2017). Significance of
differential expression was assessed using the Wald test for the coeffi-
cients of the fitted model. A more detailed description can be found in
the documentation of the Bioconductor package DESeq2 (Love et al.,
2014). The Benjamini-Hochberg algorithm, which computes False Dis-
covery Rate (FDR, adjusted P-value), was applied for correction of
multiple testing. Differentially expressed genes (DEG) were identified for
selected contrasts, i.e., pairwise comparisons. The thresholds of P-
value < 0.01 and adjusted P-value < 0.1 (i.e., FDR < 10%) were ap-
plied. Complete DEG lists for each comparison, as provided in
Supplemental Files 1–3, served for further downstream analyses. Next,
DEG were functionally characterized and enrichment scores of over-re-
presented functional categories were calculated using PANTHER soft-
ware (pantherdb.org, (Mi et al., 2017)). The web-based software In-
genuity Pathway Analysis (IPA®, Qiagen, Redwood City, California, USA)
was used to determine most significantly affected pathways and the in-
volved upstream regulators. Additionally, the Bioconductor package
goseq (Young et al., 2010) and an integrative web-based and mobile
software application Enrichr (Chen et al., 2013) were applied to support
and corroborate the results. The ClueGO v2.2.3 (Bindea et al., 2009), an
application of the open source bioinformatics software platform Cytos-
cape v3.5.1 (Shannon et al., 2003), was used to visualize enriched
functional biological networks for the pairwise comparison: “prepartum
luteolysis over mid-gestation”. In addition, Venn diagrams were gener-
ated to show overlap of DEG between selected contrasts. The input data
for Venn diagrams included an additional fold-change threshold of up-
(log2Ratio≥0.5) and down- (log2Ratio≤−0.5) regulation.
2.5. Expression of selected target genes by semi-quantitative real time
TaqMan qPCR (RT-qPCR)
In order to validate generated RNA-Seq data, the expression of
sixteen (16) selected candidate genes was evaluated. A complete list of
Table 1
List of primers and probes used for real time TaqMan qPCR (RT-qPCR).
Gene Gene name Accession number Sequence/Product no. Amplicon length
IGF-1 insulin-like growth factor I NM_001313855 Cf02627846_m1 104 bp
IGFBP3 insulin-like growth factor binding protein 3 XM_003639557 Cf02655026_g1 85 bp
IGFBP4 insulin-like growth factor binding protein 4 XM_845091 Cf02656699_m1 98 bp
IGFBP5 insulin-like growth factor binding protein 5 XM_847792 Cf02691124_s1 89 bp
INHBA inhibin, subunit beta A XM_540364 Cf02696654_u1 157 bp
INHBB inhibin, subunit beta B XM_005631933 Cf02696662_g1 83 bp
HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 XM_005620822 Cf02690463_s1 82 bp
TF transferrin XM_005634449 Cf02630418_m1 68 bp
TGFB2 transforming growth factor, beta 2 XM_545713 Cf02676764_m1 144 bp
TGFB3 transforming growth factor, beta 3 XM_849026 Cf02683792_s1 59 bp
TGFBR1 transforming growth factor, beta receptor 1 XM_014117881 Cf02687913_m1 110 bp
TGFBR2 transforming growth factor, beta receptor 2 XM_014106674 Cf02625160_m1 57 bp
CXCR2 interleukin 8 receptor, beta NM_001003151 Cf04419503_u1 84 bp
ICAM1 intercellular adhesion molecule 1 NM_001003291 Cf02690470_u1 124 bp
ADIPOQ (APM1) adiponectin, C1Q and collagen domain containing XM_005639713 Cf02703591_s1 189 bp
E2F4 E2F transcription factor 4 XM_848882 Cf02668600_m1 142 bp
RANBP3 RAN binding protein 3 MK514274 94 bp
forward 5′-ACA AGG CCA GTG AGA AGA GCA T-3′
reverse 5′-GTG TCC TTG GAA CTT GCT GAG A-3′
probe 5′-CCA GGG CGT GAA GGT TTT CTT-3′
IL-8 (CXCL8) interleukin 8 NM_001003200 114 bp
forward 5′-CCA CAC CTT TCC ATC CCA AA-3′
reverse 5′-CCA GGC ACA CCT CAT TTC CA-3′
probe 5′-CTG AGA GTG ATT GAC AGT GGC CCA CAT TGT-3′
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primers used, TaqMan-probes and pre-designed TaqMan systems is
provided in Table 1. Based on published canine CDS sequences, gene-
specific primers and probes labeled with 6-carboxyfluorescein (6-FAM)
and 6-carboxytetramethylrhodamine (TAMRA) were designed using
Primer Express Software version 2.0 (Applied Biosystems, by Thermo
Fisher Scientific, Carlsbad, CA, USA) and ordered from Microsynth,
Balgach, Switzerland. The efficiencies of PCR assays were determined
by the CT slope method ensuring approximately 100% reaction effi-
ciency (Kowalewski et al., 2011). The pre-designed TaqMan systems
were ordered from Applied Biosystems.
The validation experiments were performed using all available
(n=13) placental samples. For each sample, 10 ng of RNA were used
for downstream pre-amplification procedures. In order to eliminate
genomic DNA contamination, DNase treatment was performed using
RQ1 RNase-free DNase (Promega, Duebendorf, Switzerland). The High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was
used for reverse transcription (RT). The RT-reaction was followed by
cDNA pre-amplification, which was done using the TaqMan PreAmp
Master Mix Kit (Applied Biosystems) according to the manufacturer’s
protocol and as described previously (Nowak et al., 2017). RT-qPCR
experiments were done following our previously published protocols
(Kowalewski et al., 2006, 2011). In brief, an automated fluorometer ABI
PRISM 7500 Sequence Detection System (Applied Biosystems) was used
for all semi-quantitative analyses of target gene mRNA expression. Each
sample was run in duplicates in 96-well optical plates (Applied Bio-
systems). Autoclaved water and the so-called minus-RT controls (i.e.,
samples treated with DNase but not subjected to RT) instead of cDNA
were used as negative controls. The conditions for amplification were
set as follows: initial denaturation for 10min at 95 °C, followed by 40
cycles for 15 s at 95 °C and 1min at 60 °C, each.
2.6. Semi-quantification and normalization of target gene expression
The semi-quantification of target gene expression was done by ap-
plying the comparative Ct method (ΔΔ Ct method) according to the ABI
7500 Fast Real-Time PCR System protocol and as described previously
(Kowalewski et al., 2006, 2011). RT-qPCR data were normalized ac-
cording to two reference genes: E2F4, a transcription factor from the
E2F family, and RANBP3, a gene encoding for a protein important for
nucleocytoplasmic transport. Both reference genes were chosen from
RNA-Seq datasets presented herein and were defined as non-differen-
tially and stably expressed genes in all examined samples. The stability
of their expression was evaluated using an on-line tool RefFinder
(http://150.216.56.64/referencegene.php#, (Xie et al., 2012)) and
NormFinder software (Andersen et al., 2004). RT-qPCR data were
logarithmically transformed and are presented as geometric means
(Xg) ± geometric standard deviation (SD). An unpaired, two-tailed
Student’s t-test was done using GraphPad 3.06 (GraphPad Software Inc.,
San Diego, CA, USA) to compare the expression of target genes between
respective groups. Changes were considered significant if P < 0.05.
3. Results
3.1. Differential expression analysis (pairwise comparisons)
Differential expression analysis was done for selected experimental
conditions using the DESeq2 package for Bioconductor. Only features
(i.e., genes) with counts above the threshold of 10 reads per gene were
considered detected. Genes were assumed to be differentially expressed
(DEG=differentially expressed genes) if P < 0.01 and FDR < 0.1.
Table 2 presents a summary of the results for all tested contrasts. De-
tailed lists of DEG from respective pairwise comparisons are provided as
Supplemental Files 1–3.
3.1.1. Contrast “prepartum luteolysis over mid-gestation”
We detected 13,769 genes reaching the threshold of at least 10 reads
per gene. From these, 1973 genes were differentially expressed between
the two groups: 1034 DEG were up- and 939 were down-regulated at
prepartum luteolysis when compared to mid-gestation.
3.1.2. Contrast “antigestagen over mid-gestation”
For this contrast, 13,884 features were detected. Of the 412 DEG
initially selected based on the P < 0.01 criterium, 135 genes passed
the FDR < 0.1 correction: of these 80 genes were up- and 55 were
down-regulated in the induced luteolysis group.
3.1.3. Contrast “antigestagen over prepartum luteolysis”
For this contrast, 13,752 genes were detected. Of the 1509 DEG, 810
were more highly expressed in the antigestagen-induced luteolysis
group, and 699 were more highly expressed in the prepartum luteolysis
group.
3.2. Functional annotations
In the next step, DEG from the respective pairwise comparisons
were functionally classified according to Gene Ontology (GO) terms.
Enrichment scores were calculated for each term. All GO analyses were
done using PANTHER software, and the goseq package was used to
corroborate the results. The GO analysis covers three main functional
domains: biological process (BP), cellular compartment (CC) and mo-
lecular function (MF). Lists of representative genes involved in re-
spective enriched GO terms in each contrast are presented in
Supplemental File 4.
3.2.1. Contrast “prepartum luteolysis over mid-gestation”
Genes more highly expressed at prepartum luteolysis were strongly
associated with the following selected GO terms (Fig. 1A, Supplemental File
4): negative regulation of endothelial cell proliferation (P=4.90E−06),
negative regulation of cell-matrix adhesion (P=8.04E−04), positive reg-
ulation of cholesterol efflux (P=1.34E−04), positive regulation of insulin-
like growth factor (IGF) receptor signaling pathway (P=3.46E−04), po-
sitive regulation of cholesterol transport (P=5.91E−04), negative reg-
ulation of cell migration (P=5.35E−08), negative regulation of cell ad-
hesion (P=9.99E−05), response to extracellular stimulus
(P=4.21E−05), enzyme linked receptor protein signaling pathway
(P=1.83E−08), positive regulation of apoptotic process (P=3.15E−04)
and intracellular signal transduction (P=1.29E−03).
Functional terms overrepresented in the mid-pregnant group in-
cluded predominantly (Fig. 1A, Supplemental File 4): initiation of DNA
replication (P=1.54E−11), positive regulation of cytokinesis
(P= 4.47E−05), DNA replication (P= 1.17E−17), spindle assembly
(P= 2.90E−08), mitotic cell cycle process (P=6.02E−31), positive
regulation of cell division (P=5.86E−05), chromosome segregation
(P= 2.52E−18) and RNA processing (P=6.87E−05).
Additionally, the functional classification of genes more highly ex-
pressed in either the prepartum luteolysis or mid-gestation group was
further evaluated in the “cellular process” category, and compared to
standard categorization of the canine reference genome (Fig. 1B). Thus,
compared with the reference genome, those genes upregulated at mid-
gestation were strongly enriched in the cell cycle (31.1%) and chro-
mosome segregation (9.1%) sub-categories, which were not that
strongly pronounced at prepartum (9.9% and 1.3%, respectively). This
was also higher compared with the reference genome (16.9% and 2.1%,
from cell cycle and chromosome segregation, respectively). On the
other hand, displaying 61.6% of genes associated with cell commu-
nication, genes involved in this sub-category were increased during
prepartum luteolysis and represented 70.8%. This proportion was also
strongly increased compared with the 37% of genes associated with cell
communication during mid-gestation.
3.2.2. Contrast “antigestagen over mid-gestation”
Genes more highly represented during antigestagen-induced
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luteolysis significantly enriched GO terms associated with (Fig. 2A,
Supplemental File 4): negative regulation of cell-substrate adhesion
(P= 2.04E−05), blood coagulation (2.64E−05) and response to
wounding (3.59E−05). Higher functional variation and, therefore, no
significant terms were found for the 55 genes more highly expressed in
the mid-gestation group. Next, all 135 DEG were analyzed in the “cel-
lular process” category compared with the reference genome, revealing
an enrichment of cell communication sub-category (75% versus 61.5%)
and lower association with cell cycle (6.8%, 16.9%) (Fig. 2B).
3.2.3. Contrast “antigestagen over prepartum luteolysis”
In this contrast, we found the following terms were more highly
represented during induced luteolysis (Fig. 3, Supplemental File 4):
DNA replication initiation (P= 3.19E−10), positive regulation of cy-
tokinesis (P=1.31E−04), positive regulation of cell division
(P= 4.95E−04), positive regulation of cell cycle process
(P= 7.74E−12), extracellular matrix organization (P=1.45E−04)
and sulfur amino acid biosynthetic process (P= 4.42E−04). More
highly represented gene ontologies during prepartum luteolysis were
Table 2
Summary of RNA-Seq results for all contrasts investigated in the study. Feature counts including DEG (differentially expressed genes) numbers are presented.
Analysis Prepartum luteolysis over mid-gestation Antigestagen over mid-gestation Antigestagen over prepartum luteolysis
Genes Total (P-value < 0.01, FDR < 0.1) 1973 135 1509
Genes Up 1034 80 810
Genes Down 939 55 699
Number of genes with counts above threshold 13,769 13,884 13,752
Fig. 1. (A) Heatmap of 1973 differentially ex-
pressed genes (DEG) of the contrast “prepartum
luteolysis over mid-gestation”. Colors red to blue
indicate a gradient of high to low expression of
each gene relative to its average expression.
1034 genes were more and 939 were less highly
expressed in the prepartum luteolysis group
(P < 0.01, FDR < 0.1). The main over-
represented functional GO terms in each of the
groups are listed (statistical details are provided
in the text and Supplemental File 4). The entire
list of DEG is provided as Supplemental File 1.
(B) The functional classification of genes more
highly expressed in the prepartum luteolysis or
mid-gestation groups in the “cellular process”
category, compared with standard categoriza-
tion of the reference genome. During prepartum
luteolysis, upregulated genes were associated
mainly with “cell communication”, whereas
genes more highly expressed in the mid-gesta-
tion group were more strongly associated with
“cell cycle” sub-category.
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significantly associated with these terms: response to progesterone
(P= 9.02E−04), negative regulation of angiogenesis (P=7.88E−03),
regulation of cytokine production (P=7.58E−04), positive regulation
of protein kinase C activity (P=1.13E−03), negative regulation of cell
adhesion mediated by integrin (P=2.10E−04), positive regulation of
insulin-like growth factor (IGF) receptor signaling pathway
(P= 6.61E−04), positive regulation of cholesterol efflux
(P= 1.56E−03), positive regulation of glycolytic process
(P= 1.77E−03), positive regulation of blood coagulation
(P= 7.90E−04), and positive regulation of immune system process
(P= 1.27E−03).
3.3. Functional networks by Cytoscape
Using the ClueGO plug-in of the open source platform Cytoscape, we
functionally grouped and visualized gene ontology networks enriched
by upregulated (Fig. 4A) and downregulated genes (Fig. 4B) from the
contrast “prepartum luteolysis over mid-gestation”. For input, re-
spective lists of DEG (Supplemental File 1) were used. Networks and up
to 10 top regulated involved genes are listed in Supplemental File 4.
The most represented functional networks during prepartum luteolysis
were mainly associated with cell communication and motility, and with
modulation of vascular function and metabolic processes, and included:
vasculature development, cell motility and migration, lipid metabolic
process, regulation of cell communication and cellular response to sti-
mulus. In contrast, among networks more highly represented during
mid-gestation most prevalent were those related to proliferative activ-
ities: DNA metabolic process, chromosome segregation, cytoskeleton
organization, cell division and cell cycle.
3.4. IPA: ingenuity pathway analysis
3.4.1. Pathways
To determine the most significantly affected signaling pathways, lists
of DEG (P < 0.01, FDR < 0.1) from each comparison were used as
input for Ingenuity Pathway Analysis Software (IPA, Qiagen). A com-
prehensive list of pathways found, the representative top 10 involved
genes, as well as statistical details are presented in Supplemental File 4.
For the contrast “prepartum luteolysis over mid-gestation”, among
the most markedly enriched pathways predicted to be activated during
Fig. 2. (A) Heatmap of 135 differentially ex-
pressed genes (DEG) of the contrast “antigestagen
over mid-gestation”. Colors red to blue indicate a
gradient of high to low expression of each gene
relative to its average expression. 80 genes were
more and 55 were less highly expressed during
induced luteolysis (P < 0.01, FDR < 0.1). The
main overrepresented functional GO terms are
listed (statistical details are provided in the text
and Supplemental File 4). The entire list of DEG is
provided as Supplemental File 2. (B) The overall
functional classification of all 135 DEG in the
“cellular process” category, in comparison with
standard categorization of the reference genome.
“Cell communication” sub-category was more
enriched and “cell cycle” was less enriched when
compared to distribution of the reference genome.
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prepartum were those associated with (Fig. 5, Supplemental File 4):
immune response (IL-8 signaling, P= 2.75E−05; NF-κB signaling,
P=5.89E−03; TGF-β signaling, P= 1.58E−02; and IL-3 signaling,
P=2.40E−02), regulation of vascular function (IL-8 signaling,
P=2.75E−05; VEGF signaling, P=2.75E−03; and angiopoietin sig-
naling, P=5.50E−03), IGF-1 signaling (P=3.80E−03) and G-protein
coupled receptor signaling (Gαq signaling, P= 3.31E−02; protein ki-
nase A (PKA) signaling, P= 3.98E−02).
Among significant pathways that were predicted to be inhibited in
the prepartum luteolysis group we found: mitotic roles of polo-like ki-
nase (P=1.66E−06), cyclins and cell cycle regulation
(P= 2.69E−04), leukocyte extravasation signaling (P=1.02E−03)
and PPAR signaling (P=2.69E−02).
Regarding the contrast “antigestagen over mid-gestation”, among
the most highly enriched pathways were (Fig. 6, Supplemental File 4):
inhibition of matrix metalloproteases (P=6.92E−05), intrinsic pro-
thrombin activation pathway (P= 9.33E−05), coagulation system
(P= 1.66E−02), granulocyte adhesion and diapedesis
(P= 1.91E−02), leukocyte extravasation signaling (P=3.24E−02),
HIF1α signaling (P=2.95E−02), IL-8 signaling (P= 2.57E−02) and
glucocorticoid receptor signaling (P= 4.37E−02).
Finally, the most significantly affected pathways in the comparison
“antigestagen over prepartum luteolysis” (Fig. 7, Supplemental File 4)
were similar to those observed for the contrast “prepartum luteolysis
over mid-gestation” and were represented by, e.g.,: IL-8 signaling
(P= 6.46E−06), TGF-β signaling (P= 5.75E−04), Gαq signaling
(P= 2.14E−03), NF-κB signaling (P=8.51E−03), endothelin-1 sig-
naling (P= 2.4E−02) and PKA signaling (P= 1.26E−02), but the
activation of most of these pathways was potentiated more during
prepartum than antigestagen-induced luteolysis.
3.4.2. Upstream regulators and potential P4-regulated genes
Additionally, IPA® software was used to identify upstream reg-
ulators, i.e., molecules such as transcriptional factors and cytokines,
which can affect the expression of a given population of genes in a
specific manner. DEG from the contrasts “prepartum luteolysis over
mid-gestation” and “antigestagen over mid-gestation” were found to be
affected upstream by: P4, PGR, TNF, dexamethasone, TGF-β, IGF-1 and
PPARγ (for statistical details see Supplemental File 4). In the contrast
“antigestagen over prepartum luteolysis”, among the most represented
upstream regulators, we identified TGF-β, dexamethasone, P4 and PGR.
The first two molecules, i.e., TGF-β and dexamethasone appeared to be
more enriched during prepartum luteolysis.
Further, because withdrawal of P4 is crucial for initiation of par-
turition and, as presented above, this hormone was identified as an
important upstream regulating molecule in the analyzed datasets, we
used IPA® to examine expression of genes potentially affected by P4,
i.e., P4-regulated genes. Thus, for the comparison “prepartum luteolysis
over mid-gestation” 127 genes were found to be potentially influenced
by P4 (Fig. 8A). Among them were, i.a.: matrix metalloproteases
(MMP1, MMP2, MMP9, MMP13), ICAM1, members of the IGF- (IGF1,
IGFBP3, IGFBP5) and TGF-β-systems (TGFβ3, TGFBR1), ADIPOQ, PRLR,
VEGFA, PTGS2 and HSD11B2. Regarding the comparison “antigestagen
over mid-gestation”, 14 genes were identified as potentially affected by
P4 (Fig. 8B). Nine of these genes, ERRFI1, F2RL1, Gstt1, HSD11B2,
IGFBP5, LPL, MMP1, PARM1 and SPHK1, were found in both datasets
and their expression was regulated in the same manner, i.e., either up-
or down-regulated.
3.5. Venn diagrams
To reveal similarities and differences in the placental transcriptome
from natural, i.e., prepartum, vs. induced luteolysis, the intersections of
DEG from contrasts “prepartum luteolysis over mid-gestation” vs. “an-
tigestagen over mid-gestation” were visualized using Venn diagrams
(Fig. 9). As an input we used all DEG (P < 0.01, FDR < 0.1, log2-
Ratio > 0.5 for upregulated genes, or<−0.5 for downregulated
genes) from each contrast. Expression of 83 genes (regardless of log2-
Ratio) was altered in both contrasts. Interestingly, all overlapped genes
were regulated in the same manner in each comparison, i.e. 48 genes
were up- (log2Ratio > 0.5) and 35 genes were down-regulated (log2-
Ratio < −0.5) in the prepartum luteolysis and antigestagen-induced
luteolysis groups compared to mid-gestation. These genes were asso-
ciated with functional terms related to cellular death, vascular lesions
and migration of immune cells. The complete list of genes from each
intersection as well as enriched functional terms by commonly regu-
lated genes with statistical details is provided in Supplemental File 5.
3.6. Expression of candidate target genes
Semi-quantitative real time TaqMan qPCR (RT-qPCR) was applied
to evaluate the expression of sixteen (16) selected target genes, which
were chosen from DEG from particular contrasts (Fig. 10, Supplemental
File 6). Candidates included representative genes from the following
functional groups, identified as being affected during either prepartum
or/and abortion: IGF system (IGF-1, IGFBP3, IGFBP4, IGFBP5), TGF-β
Fig. 3. Heatmap of 1509 differentially expressed
genes (DEG) of the contrast “antigestagen over
prepartum luteolysis”. Colors red to blue indicate
a gradient of high to low expression of each gene
relative to its average expression. 810 genes were
more highly expressed in the antigestagen-in-
duced luteolysis group, whereas 699 were more
highly expressed during prepartum luteolysis
(P < 0.01, FDR < 0.1). The main over-
represented functional GO terms in each of the
groups are listed (statistical details are provided in
the text and Supplemental File 4). The entire list
of DEG is provided as Supplemental File 3.
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Fig. 4. Functional networks of the contrast “prepartum luteolysis over mid-gestation” by ClueGO application of Cytoscape. The functional terms overrepresented in
each group are shown. Redundant and non-informative terms were removed, and the resulting network was manually rearranged. The number of mapped genes is
indicated by the node size, whereas the level of enhancement is denoted by node color (see figure legend). The most represented functional networks during
prepartum luteolysis (upper scheme) were associated with: vasculature development, cell motility and migration, lipid metabolic processes, regulation of cell
communication, and cellular response to stimulus. Networks more highly represented during mid-gestation (lower scheme) were related to DNA metabolic processes,
chromosome segregation, cytoskeleton organization, cell division and cell cycle.
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system (TGFBETA2, TGFBETA3, TGFBR1, TGFBR2), IL-8 (CXCL8) and
its receptor (CXCR2) and potential P4 targets (ICAM1, HSD11B2,
ADIPOQ). Additionally, inhibin subunits beta (INHBA, INHBB) and
transferrin (TF) were included in the group of targets for data valida-
tion. Generally, results from RT-qPCR and RNA-Seq were well corre-
lated. Thus, expression of IGF system members was upregulated in
prepartum luteolysis in comparison to the mid-gestation group
(Fig. 10A, Supplemental File 6). Additionally, for the contrast “pre-
partum luteolysis over mid-gestation”, increased expression of the TGF-
β system was observed, except for TGFBETA2 (Fig. 10A). The latter as
well as IL-8 (CXCL2) did not vary significantly in RT-qPCR between the
two experimental groups, although their expression was predicted to be
increased by RNA-Seq results. In addition, during prepartum luteolysis,
expression of both inhibin subunits beta (INHBA, INHBB), TF, ICAM1
and ADIPOQ was also increased (Fig. 10A). Regarding HSD11B2, its
expression was downregulated in both prepartum and induced luteo-
lysis when compared to mid-gestation (Fig. 10A and B). Moreover, in
the contrast “antigestagen over mid-gestation”, a significant increase of
IGFBP5 was found in samples derived from the antigestagen-treated
group (Fig. 10B, Supplemental File 6). The expression of TF, however,
did not differ, although it was predicted to be upregulated in the RNA-
Seq dataset. Comparison of induced luteolysis and prepartum luteolysis
groups revealed higher expression of almost all investigated target
genes (i.e., IGF1, IGFBP3, IGFBP4, INHBA, INHBB, TGFBETA2,
TGFBETA3, TGFBR2, ADIPOQ) during natural prepartum (Fig. 10C,
Supplemental File 6). On the other hand, HSD11B2 was more highly
Fig. 5. The canonical pathways enriched for the comparison “prepartum luteolysis over mid-gestation” ranked according to –log (P-value). The color (orange to blue)
indicates predicted activity pattern of a given pathway at prepartum luteolysis: blue for inhibition, orange for activation. The overlapping of gene sets is indicated by
the orange line (Ratio).
M. Nowak, et al. General and Comparative Endocrinology 282 (2019) 113194
9
expressed during induced luteolysis (Fig. 10C). Finally, expression of
CXCR2, i.e., IL-8 receptor, did not significantly differ between these two
conditions, but its expression was predicted to be higher in the induced
luteolysis group.
4. Discussion
The cascade initiating parturition in the dog seems to be regulated
at the level of the nuclear P4 receptor localized in the maternal part of
the placenta (Kowalewski et al., 2010). Despite individual, diurnal and
breed-associated fluctuations in peripheral P4 concentrations, labor is
observed in bitches at approximately 63+/− 2 days after mating. At
that time, circulating P4 levels typically drop below 2–3 ng/ml
(Concannon et al., 1989; Hoffmann et al., 1994; Verstegen-Onclin and
Verstegen, 2008). A simultaneous increase in PGF2α, most probably
acting as both a luteolytic and a uterotonic factor, is observed (Nohr
et al., 1993). However, the molecular regulation of the cascade in-
itiating parturition in the dog and its involvement in the underlying
feto-maternal communication has not yet been completely elucidated.
In particular, the complex P4-mediated effects remain to be better un-
derstood. Therefore, here, by applying next generation sequencing
techniques, we investigated global transcriptome changes in the canine
placenta. Mid-term placentae were compared with normal and anti-
gestagen-induced luteolysis. A further, clinically important, comparison
was made between the two luteolytic groups, to reveal molecular me-
chanisms underlying physiological parturition and abortion.
4.1. Prepartum luteolysis
When compared with mid-gestation, the prepartum placenta was
characterized by the strong presence of functional terms associated with
active apoptosis as well as impaired cellular adhesion and proliferation,
with particular respect to endothelial cells. This was also reflected in the
overall classification of identified genes compared with the reference
genome. This pointed towards a functional shift from proliferation-as-
sociated processes prevailing during mid-gestation to increased cell
communication and suppressed proliferative activities during the pre-
partum luteolysis. The observed changes were further mirrored in
overrepresented functional networks and in a perturbed balance between
two angiogenic factors, ANGPT2 and VEGFA. Thus, whereas ANGPT2
was strongly upregulated, the expression of VEGFA was decreased in our
dataset during prepartum luteolysis. In regard to VEGFA, our RNA-Seq
findings corroborate the previously observed decreased expression of
VEGFA in canine utero-placental units at prepartum (Gram et al., 2015a).
A functional interchange between ANGPT2 and VEGFA has been shown
before (Maisonpierre et al., 1997). Accordingly, in the presence of
VEGFA, ANGPT2 serves as an angiogenic signal, promoting endothelial
cell migration and proliferation. However, in the absence of VEGFA,
ANGPT2 causes loosening of cell-matrix adhesion, thereby contributing
to endothelial cell apoptosis and consequently to vascular degeneration
(Hanahan, 1997; Maisonpierre et al., 1997). Whether this mechanism
applies to the canine placenta and contributes to vascular disintegration
and, possibly, to the post-partum detachment of the placenta in the dog,
needs to be further clarified. Interestingly, however, following this idea,
we identified ICAM1, an intercellular adhesion molecule, among the
factors more highly represented at prepartum luteolysis. Its role is as-
sociated with loosening of the barrier function of endothelial cells (Yang
et al., 2005; Anbarasan et al., 2015). Under normal, physiological con-
ditions, ICAM1 is stable and expressed at a relatively low level in en-
dothelial cells (Anbarasan et al., 2015). However, in response to in-
flammatory mediators such as TNF, the expression of ICAM1
dramatically increases, promoting the attachment of leukocytes to en-
dothelial cells, recruiting them to the sites of inflammation and thereby
facilitating migration of leukocytes (Yang et al., 2005; Anbarasan et al.,
2015). Besides loosening cell-to-cell contacts in endothelial cells, ICAM1
also stimulates local production of pro-inflammatory cytokines and
Fig. 6. The canonical pathways enriched for the comparison “antigestagen over mid-gestation” ranked according to –log (P-value). The color indicates predicted
activity pattern of a given pathway in the induced luteolysis group: whereas orange indicates activation; for white and grey, although enriched, no activation status
could be predicted from the software (no activity pattern available). The overlapping of gene sets is indicated by the orange line (Ratio).
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chemokines, additionally attracting immune cells to inflamed areas
(Yang et al., 2005; Ramos et al., 2014). In this regard, pathways re-
cognized to be activated at prepartum, like IL-8-, IL-3-, eNOS-, RhoA- and
NO-signaling, further imply essential involvement of mechanisms reg-
ulating disruption of placental vascular function during the onset of ca-
nine labor. It is noteworthy that these processes seem to occur in parallel,
or as a result of local modulation of immune system directed towards
inflammation. This was further emphasized in our dataset by strong
enrichment of proinflammatory pathways, such as NF-κB-, AMPK- and
TGF-β-mediated signaling. TGF-β is a multifunctional cytokine, whose
effects are tissue and/or condition-specific, but generally include anti-
proliferative, anti-angiogenic and pro-apoptotic actions (Jones et al.,
2006; Kubiczkova et al., 2012; Massague, 2012). The involvement of
TGF-β-mediated signaling in active luteolysis was addressed in cattle
(Maroni and Davis, 2011, 2012) and discussed for the canine species
(Zatta et al., 2017). Additionally, a possible role of TGF-β in fetal
membrane detachment was proposed for cattle (Hirayama et al., 2015).
In the data set presented herein, increased placental expression of several
members of the TGF-β-system, i.e., TGFBETA3, TGFBR1 and TGFBR2,
was confirmed by RT-qPCR during prepartum. In view of the above-
mentioned facts and our own observations, the TGF-β-family comes
across as being important molecules in the dog. Further mechanistic
studies are required to determine the role of TGF-β in the utero-placental
signaling cascade initiating canine labor.
It needs to be emphasized that functional changes implied from the
comparison of transcriptomes between prepartum luteolysis, re-
presenting late placenta, and mid-term placenta are certainly ad-
ditionally influenced by the continuous exposure to gradually de-
creasing P4 levels during the second half of gestation and are thereby
time-related. These time-related processes could be referred to as the
process of placental maturation towards preparation for parturition. In
a broader sense, this could also provide, at least in part, an explanation
for lower PGF2α levels induced in the placenta during the pre-term
withdrawal of P4, compared with natural luteolysis (Baan et al., 2008;
Kowalewski et al., 2010). The process of placental maturation and
aging of the placenta is also seen in the functional terms more strongly
represented during mid-gestation and relating to increased proliferative
activity, e.g., initiation of DNA replication or positive regulation of cell
division and chromosome segregation, which all cease in the late term
placenta.
We have also validated the expression of two subunits of inhibin
beta: inhibin beta A (INHBA) and inhibin beta B (INHBB), which are
Fig. 7. The canonical pathways enriched for the comparison “antigestagen over prepartum luteolysis” ranked according to –log (P-value). The blue color indicates
predicted inhibition of a given pathway at antigestagen-induced luteolysis (in reference to normal prepartum luteolysis). The overlapping of gene sets is indicated by
orange line (Ratio).
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members of the family of inhibin-related proteins. Their expression was
significantly increased during prepartum and was more strongly re-
presented at normal than during induced parturition. This group of
proteins belongs structurally to the TGF-β family, and includes activins
and inhibins (Wijayarathna and de Kretser, 2016). It needs to be clar-
ified that structural differences, and consequently opposing functional
properties between activins and inhibins, exist in their subunit com-
positions. Whereas activins are homo- or hetero-dimers composed of
two beta subunits (INHBA or INHBB), and thus are called activin A, AB
or B, respectively, inhibins are heterodimers of subunit alpha (INHA)
and any one of the beta subunits (Wijayarathna and de Kretser, 2016).
In the present study, the expression of subunit alpha was not verified by
RT-qPCR, as it did not vary in any RNA-seq dataset. On the other hand,
increased expression of INHBA as well as INHBB was found in the
prepartum luteolysis group. This finding, together with unchanged
expression of subunit alpha, implies preferential synthesis in favor of
activins. Similarly, in women, serum activin A peaks at 38–39weeks of
pregnancy (O’Connor et al., 1999; Wijayarathna and de Kretser, 2016),
and rapidly drops following delivery, indicating its role at the end of
gestation. Activins appear to act as pro-inflammatory and proapoptotic
agents (Jones et al., 2006; Wijayarathna and de Kretser, 2016), and are
known to affect functions of endothelial cells, which show signs of
oxidative stress when exposed to activins (Yu et al., 2012). Cumula-
tively, in the canine placenta activins could be involved in prepartum-
associated modulation of immune and vascular functions and therefore
merit more attention in future.
As already mentioned, among significantly enriched functional terms
and networks during prepartum luteolysis were those related to in-
tracellular signal transduction and cell communication, indicating
intensified cellular cross-talk in the placenta prior to delivery. Moreover,
enhanced cellular communication was reflected in activated pathways,
like IGF1 signaling, G-protein-coupled receptor signaling or PKA
pathway. Insulin-like growth factors (IGFs) are growth-promoting pep-
tides which stimulate cell proliferation and differentiation (Jones and
Clemmons, 1995). Their bioavailability and signaling is dependent on
the presence of IGF binding proteins (IGFBPs), which by interfering with
IGFs may affect their half-life and affinity for receptors (Jones and
Clemmons, 1995; Allard and Duan, 2018). The majority of IGF effects
have been described predominantly for early stages of pregnancy. Thus,
during human gestation, they were shown to be important for pla-
centation and fetal development (Fowden, 2003; Hiden et al., 2009;
Lauszus and Fuglsang, 2016). Their role has been addressed also for the
dog, in which IGFs serve as markers of decidualization (Kautz et al.,
2014). On the other hand, only sparse information is available about
expression of IGFs, their signaling and possible actions prior to parturi-
tion. In the dataset presented herein, we have observed, and confirmed
by RT-qPCR, increased availability of transcripts encoding for placental
IGF1 and several IGFBPs in the prepartum luteolysis group. Similarly, in
humans, serum maternal IGF1 gradually increases throughout preg-
nancy, reaching its highest levels around the 37th week of gestation
(Wiesli et al., 2006). The potential role of these increased levels of IGF1
during human gestation is considered to be related to the secretion of
placental growth hormone (GH) (Caufriez et al., 1990). Regrettably,
nothing is known about synthesis and secretion of GH in the canine
placenta, and our data are the first to report increased placental IGF1
expression at term in this species. Therefore, a potential relationship
between GH and IGF1 during late stages of canine gestation, as described
for humans, remains unclear and certainly raises a topic worth further
Fig. 8. Genes potentially regulated by progesterone (P4) as determined by Ingenuity Pathway Analysis (IPA®, Qiagen) in (A) prepartum luteolysis and (B) induced
luteolysis group. Highlighted in orange are genes found to be common for both groups. For abbreviations see Supplemental File 7.
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investigation. The possible endocrine functions of IGF1 in the maternal
circulation, e.g., in supporting development of the mammary gland,
should be taken into consideration (Duclos et al., 1989; Macias and
Hinck, 2012; Bao et al., 2016).
Remarkably, among the overrepresented functional networks linked
to prepartum luteolysis we identified terms and genes related to posi-
tive metabolism of lipids, particularly to cholesterol. In this context,
even more interesting was the detection of decreased levels of
HSD11B2. Its lower expression at prepartum was confirmed by qPCR.
HSD11B2 is responsible for conversion of cortisol to its inactive form,
cortisone (Ulick et al., 1977; Funder et al., 1988). This observation has
drawn our attention to the potential involvement of cortisol in canine
parturition. Admittedly, the role of placental HSD11B2 has been ad-
dressed in other species, like sheep, humans and rats (Murphy et al.,
1974; Sun et al., 1999; Clarke et al., 2002; Mark et al., 2009), and its
increased expression has been considered to be protective in preventing
overexposure of the fetus and placenta to high maternal cortisol levels
secreted, for example, in response to stress (Sun et al., 1998; Burton and
Waddell, 1999). The decreased expression of HSD11B2 observed herein
somewhat resembles the situation reported in the prepartum sheep
placenta, in which HSD11B2was suppressed (Clarke et al., 2002). In the
ovine species, however, the low prepartum HSD11B2 was pre-
dominantly attributed to enhancement of fetal cortisol facilitating
placental estrogen steroidogenesis (Mason et al., 1989). Such a me-
chanism is clearly precluded in dogs because they lack placental ster-
oidogenesis (Hoffmann et al., 1994; Nishiyama et al., 1999). Never-
theless, as mentioned elsewhere, the function of cortisol during the
parturition cascade in dogs has been discussed before (Concannon
et al., 1978; Hoffmann et al., 1994; Veronesi et al., 2002). In fact, in
some studies, glucocorticoids were used to terminate gestation in the
dog (Austad et al., 1976; Zone et al., 1995; Wanke et al., 1997).
However, since high dosages and repeated applications were required,
whether this reflects the normal prepartum cascade is questionable. The
possible action of glucocorticoids at prepartum in the dog should be
considered in the context of availability of their receptor (GR/NR3C1),
as it might be important for the functional withdrawal of P4 at the
placental level (Gram et al., 2016). Accordingly, although placental
expression of GR/NR3C1 is elevated at normal prepartum luteolysis, it
does not appear to be crucial for induction of the prostaglandin cascade
(Gram et al., 2016). The role of cortisol in regulating the expression and
Fig. 9. Venn diagrams showing the distribution
and overlap of DEG between the contrasts “pre-
partum luteolysis over mid-gestation” and “anti-
gestagen over mid-gestation”. As an input, lists of
DEG (P < 0.01, FDR < 0.1) from respective
comparisons were used. Presented are overlaps of:
all DEG (log2Ratio > 0.5 or < -0.5), upregu-
lated genes (log2Ratio > 0.5) and downregulated
genes (log2Ratio < -0.5). When full sets of genes
were used, 83 genes were found in both contrasts.
They revealed the same direction of regulation in
each comparison, i.e.: 48 genes were up- and 35
genes were down-regulated in prepartum luteo-
lysis and antigestagen-induced luteolysis groups
compared with mid-gestation. The complete list of
genes from each intersection is provided in
Supplemental File 5.
M. Nowak, et al. General and Comparative Endocrinology 282 (2019) 113194
13
function of its own receptor in the canine placenta, although not yet
described, should also be considered. Finally, although the overall
systemic concentrations of cortisol in parturient bitches vary strongly
individually (Concannon et al., 1978; Hoffmann et al., 1994; Veronesi
et al., 2002), nothing is known about its local levels in the placenta, or
about the contribution of the fetal HPA axis to cortisol production.
Therefore, in view of these facts and our current results, it appears
plausible that HSD11B2 could be involved in enhancing local avail-
ability of cortisol prior to term, but the consequences of this event still
need to be explored.
4.2. Antigestagen-induced changes
As evidenced from some previous studies, interfering with PGR
function by treatment with the antigestagen aglepristone results in the
cessation of luteal function, a rise in peripheral PGF2α and abortion. In
order to better understand mechanisms underlying the antigestagen-
induced termination of canine pregnancy, we compared placental
transcriptomes of aglepristone-treated mid-term bitches with non-
treated controls at the same stage of pregnancy. In this context, it is of
fundamental importance to understand that the end result of aglepris-
tone treatment, i.e., abortion, results from the reciprocal placental feto-
maternal communication (see review in (Kowalewski et al., 2015)). By
establishing this contrast, we shed light on the role of functional
withdrawal of P4 at the level of its nuclear receptor PGR.
As revealed by downstream analysis of 135 DEG, the changes in
placental transcriptome induced by antigestagen treatment to a great
extent matched those changes observed during natural prepartum. This
was reflected in overall functional representation of genes in reference
to the whole canine genome, clearly indicating a functional shift to-
wards the cell communication sub-cluster, with fewer genes being
linked to cell cycle and proliferation sub-groups. Also, functional terms
and pathways referred predominantly to alterations in placental vas-
cularity and activation of the immune system. These observations are
also consistent with a study describing morphological changes in the
placenta in dogs after aglepristone treatment (Steiger et al., 2006).
Fig. 10. The relative gene expression (RGE) of candidate genes as determined by real-time TaqMan qPCR (RT-qPCR). Numerical data are presented on a logarithmic
scale as geometric means Xg ± geometric standard deviation (SD). An unpaired, two-tailed Student’s t-test was applied. An asterisk indicates statistical significance
between the particular groups (P < 0.05). See Table 1 for abbreviations and Supplemental File 6 for statistical details.
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These changes included degeneration of the placental labyrinth, en-
dothelial swelling and detachment of the trophoblast, and correspond
with the increased hypoxia and endothelin signaling found in the pre-
sent study. The potential involvement of endothelins in initiating the
signaling cascade of prostaglandin synthesis during normal and induced
parturition in the dog was also implied in some previous studies (Gram
et al., 2015b, 2017).
4.3. Normal vs. induced luteolysis and P4-mediated genes
In our next step, common changes induced in placental tran-
scriptomes during normal and induced luteolysis in reference to mid-
gestation were visualized using Venn diagrams. Notably, all of the 83
commonly expressed genes were regulated in the same manner, i.e.,
were either upregulated or downregulated under both conditions, and
were associated predominantly with cellular death, vascular lesion and
cellular infiltration by immune cells.
They also shared similar upstream regulators, such as TNF, TGF-β,
IGF1, PPARG and dexamethasone. This even more strongly highlights
the importance of P4/PGR, and of maternal decidual cells, in control-
ling the maintenance and termination of pregnancy in the dog. In this
context, being expressed solely in the fetal trophoblast throughout ca-
nine gestation, the functional involvement of PPARG in regulating ca-
nine placental function was suggested from a previous study
(Kowalewski et al., 2011). PPARG is indeed an interesting candidate
gene as it acts as an alternative receptor for arachidonic acid-derived
metabolites, such as prostaglandins (Berger and Moller, 2002). Its
withdrawal during normal and antigestagen-induced luteolysis may
play a functional role during the prepartum endocrine cascade in the
dog, leading to detachment of the placenta (Kowalewski et al., 2011).
Therefore, in the next step, our focus was on the identification of P4-
mediated genes. By applying IPA® software, the majority of the genes
found in the contrast “induced luteolysis over mid-gestation” was also
observed in the natural prepartum luteolysis group, further empha-
sizing the similarity of molecular pathways activated in both condi-
tions, and supporting our previously postulated hypothesis of the im-
portance of P4 withdrawal for initiation of the luteal cascade in the dog
(Kowalewski et al., 2010). Among representative P4-mediated genes
revealing similar expression patterns under both conditions were:
HSD11B2 and IGFBP5 (one of the IGFs binding proteins, (Schneider
et al., 2002)), F2RL1 (mediator of immune response, involved in sti-
mulation of IL-8 release (Asokananthan et al., 2002)) and MMP1 (in-
volved in extracellular matrix remodeling, implicated in the rupture of
fetal membranes at labor in women (Maymon et al., 2000)). In view of
these observations, P4, acting through PGR, appears to be among the
key molecules determining placental integrity in the dog. Moreover,
based on our findings in the abortion group, P4 functions include vas-
cular maintenance, support of proliferation of cells, and immune
system-related effects pointing towards immunosuppression.
4.4. Similar but not the same: defining molecular differences of clinical
importance between natural parturition and abortion induced at mid-term
Although, as indicated above, the signatures of molecular changes
occurring at antigestagen-induced abortion appeared similar to those
observed during normal prepartum, however, clinical observations in-
dicate important differences between these two processes (Hoffmann
et al., 1999; Fieni et al., 2001). Firstly, the increase of PGF2α in the
maternal circulation of antigestagen-treated dogs, although sufficient
for luteolysis, does not closely reflect the concentrations observed
during normal prepartum (Nohr et al., 1993; Hoffmann et al., 1999;
Baan et al., 2008). This was also reflected in our dataset showing higher
representation of prostaglandin-related pathways by placing PTGS2/
COX2 among the top P4-regulated genes during normal but not during
induced luteolysis. Consequently, at the clinical level, uterine contrac-
tions appear weaker and the passage of fetuses is hindered (Galac et al.,
2000; Pettersson and Tidholm, 2009; Rigau et al., 2011). This, in turn,
results in extended duration of abortion. Moreover, in contrast with
normal prepartum luteolysis, there is no utero-placental increase in
glucocorticoid receptors (GR/NR3C1) following antigestagen treatment
(Gram et al., 2016). The underlying molecular mechanisms of parturi-
tion and abortion were investigated previously, but predominantly in
the context of normally developing pregnancy, and have not been
compared between each other. Therefore, aiming to provide better
understanding of the physiology of canine labor and to determine dif-
ferences between parturition and abortion at the molecular level that
could have been overlooked in previous studies, we compared placental
transcriptomes between antigestagen-induced luteolysis and prepartum
luteolysis. We found a high number (1509) of DEG between these two
groups. Generally, genes more highly expressed during natural pre-
partum were associated with similar functional terms as observed for
prepartum luteolysis when compared to mid-gestation. This included
negative regulation of angiogenesis, immune system related processes
and cytokine production. Similarly, most of the identified pathways
(e.g., IL8-, TGF-β-, NF-κB-, or PKA-signaling) were in accordance with
those observed for the pairwise comparison “prepartum luteolysis over
mid-gestation”, and showed higher enrichment and activation for the
prepartum than induced luteolysis groups. This was also supported by
higher expression of candidate genes found by qPCR, indicating, e.g.,
higher expression of the TGF-β system. Thus, although sharing similar
P4-dependent pathways important for initializing the luteolytic cas-
cade, both induced and normal parturition appear to differ at the level
of enhancement of the underlying signaling cascades, leading to dif-
ferences at the clinical level. These differences could relate to the
aforementioned maturation of the canine placenta towards prepartum.
Continuous exposure to decreasing P4 levels and ageing processes could
play roles in the underlying mechanisms.
5. Conclusions
Here, for the first time the RNA-seq approach has been applied to
investigate global transcriptome changes in the canine placenta associated
with the initiation of parturition. The data presented herein contribute to
better understanding of the prepartum cascade initialized in the placenta,
in particular with regard to underlying cell-to-cell cross talk between the
maternal and fetal compartments. Events occurring in the placenta at term
appear to be predominantly associated with apoptosis, immune system
activation and disturbance of vasculature. Ultimately, besides inducing
prepartum PGF2α release, these processes lead to detachment of the
placenta and expulsion of fetuses.
By studying transcriptomic changes induced by antigestagen treat-
ment, potential P4-mediated genes and effects could be distinguished
and referred to pre-parturient events. Moreover, several hypotheses
were put forward and factors not previously considered were identified,
providing a basis for further investigations of the molecular and en-
docrine cascade terminating canine gestation. However, because our
study involved a rather low number of animals, our findings are not
definitive, and further studies with larger numbers of animals are re-
quired to support and verify our hypotheses. Nevertheless, some of the
factors, like activins, the IGF and TGF systems or locally acting cortisol,
certainly deserve closer attention and should determine future research
directions.
The similarity of the identified changes between natural and agle-
pristone-induced luteolysis further highlights the importance of P4 and
of PGR-expressing decidual cells at the onset of luteolysis.
From the clinical point of view the difference in levels of activation
of molecular pathways and functional networks between normal and
induced luteolysis needs to be taken into account. It indicates an im-
portant role for temporal exposure of the placenta to gradually de-
creasing P4, which needs to be examined further in order to be trans-
lated into clinical relevance.
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